A Trial to Evaluate Renal Artery Denervation in Addition to Catheter Ablation to Eliminate
Atrial Fibrillation (ERADICATE-AF II)
Research Question:
Does treat for atrial fibrillation work equally well in patients with controlled high
blood pressure versus people without high blood pressure?
Basic Study Information
Purpose:
People with atrial fibrillation (AF) have a heart that beats irregularly. This can
cause symptoms such as shortness of breath, chest pain, and fatigue.
There is no cure for AF, but there are treatments that can help to control the symptoms
and prevent complications. One treatment is called catheter ablation. Catheter ablation
is a procedure that uses heat or cold to destroy small areas of the heart that are
causing the AF.
Another treatment for AF is called renal artery denervation (RDN). RDN in combination
with catheter ablation is better at treating AF than catheter ablation alone.
This study will determine if RDN plus catheter ablation works equally well in people
with controlled high blood pressure or without high blood pressure.
Study Reference #: STUDY00007297
Lead Researcher (Principal Investigator)
Lead Researcher:
Jonathan Steinberg
Study Contact Information
Study Coordinator: Jonathan Steinberg, MD
Phone: (973) 436-4155
Email: jsteinberg@smgnj.com
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search